119 related articles for article (PubMed ID: 8682061)
1. Does ACE inhibition limit structural changes in the heart following myocardial infarction?
Smits JF; Passier RC; Nelissen-Vrancken HJ; Cleutjens JP; Kuizinga MC; Daemen MJ
Eur Heart J; 1995 Dec; 16 Suppl N():46-51. PubMed ID: 8682061
[TBL] [Abstract][Full Text] [Related]
2. Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy.
Zhu YC; Zhu YZ; Gohlke P; Stauss HM; Unger T
Am J Cardiol; 1997 Aug; 80(3A):110A-117A. PubMed ID: 9293963
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
4. Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling.
Lijnen PJ; Petrov VV
Methods Find Exp Clin Pharmacol; 2003 Sep; 25(7):541-64. PubMed ID: 14571285
[TBL] [Abstract][Full Text] [Related]
5. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
[TBL] [Abstract][Full Text] [Related]
6. Role of ACE inhibition or AT1 blockade in the remodeling following myocardial infarction.
Holtz J
Basic Res Cardiol; 1998; 93 Suppl 2():92-100. PubMed ID: 9833170
[TBL] [Abstract][Full Text] [Related]
7. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
[TBL] [Abstract][Full Text] [Related]
8. Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
Li C; Han R; Kang L; Wang J; Gao Y; Li Y; He J; Tian J
Sci Rep; 2017 Jan; 7():40523. PubMed ID: 28091615
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the Renin-Angiotensin System Post Myocardial Infarction Prevents Inflammation-Associated Acute Cardiac Rupture.
Gao XM; Tsai A; Al-Sharea A; Su Y; Moore S; Han LP; Kiriazis H; Dart AM; Murphy AJ; Du XJ
Cardiovasc Drugs Ther; 2017 Apr; 31(2):145-156. PubMed ID: 28204966
[TBL] [Abstract][Full Text] [Related]
10. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects.
Falkenhahn M; Gohlke P; Paul M; Stoll M; Unger T
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S6-13. PubMed ID: 7898096
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of cardiac fibroblast function.
Brilla CG; Maisch B; Rupp H; Funck R; Zhou G; Weber KT
Herz; 1995 Apr; 20(2):127-34. PubMed ID: 7774864
[TBL] [Abstract][Full Text] [Related]
13. Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes.
Bäcklund T; Lakkisto P; Palojoki E; Grönholm T; Saraste A; Finckenberg P; Mervaala E; Tikkanen I; Laine M
J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):66-73. PubMed ID: 17703432
[TBL] [Abstract][Full Text] [Related]
14. Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover.
Brilla CG; Zhou G; Rupp H; Maisch B; Weber KT
Am J Cardiol; 1995 Nov; 76(13):8D-13D. PubMed ID: 7495221
[TBL] [Abstract][Full Text] [Related]
15. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.
Brilla CG; Rupp H; Funck R; Maisch B
Eur Heart J; 1995 Dec; 16 Suppl O():107-9. PubMed ID: 8682074
[TBL] [Abstract][Full Text] [Related]
16. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
Lijnen P; Petrov V
J Mol Cell Cardiol; 1999 May; 31(5):949-70. PubMed ID: 10336836
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the structural remodelling of the myocardium: from hypertrophy to heart failure.
Brilla CG; Maisch B
Eur Heart J; 1994 Dec; 15 Suppl D():45-52. PubMed ID: 7713113
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril and angiotensin II receptor blockers (AT1, AT2) on myocardial ischemia-reperfusion induced infarct size.
Parlakpinar H; Ozer MK; Acet A
Cytokine; 2011 Dec; 56(3):688-94. PubMed ID: 21975128
[TBL] [Abstract][Full Text] [Related]
19. Heart failure, ventricular remodelling and the renin-angiotensin system: insights from recently completed clinical trials.
Young JB
Eur Heart J; 1993 Jul; 14 Suppl C():14-7. PubMed ID: 8365422
[TBL] [Abstract][Full Text] [Related]
20. Renin-angiotensin system and myocardial collagen matrix: modulation of cardiac fibroblast function by angiotensin II type 1 receptor antagonism.
Brilla CG; Scheer C; Rupp H
J Hypertens Suppl; 1997 Dec; 15(6):S13-9. PubMed ID: 9493122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
